Children's Health Defense
U.S. Senate Finance Committee members who will vote first on Robert F. Kennedy Jr.’s nomination for U.S. Department of Health and Human Services (HHS) secretary individually have accepted “hundreds of thousands of dollars in contributions from the pharmaceutical industry,” The Federalist reported.
“Republicans overall brought in nearly $5 million from the pharmaceutical industry across 13 members while Democrats raised more than $1.7 million across 9,” according to The Federalist.
Earlier this month, President-elect Donald Trump nominated Kennedy, founder of Children’s Health Defense (CHD), to lead HHS. The Senate Finance Committee, which will attain a Republican majority in the new Trump administration, will hold confirmation hearings for Kennedy in January.
Kennedy’s nomination has Big Pharma “bracing for generational changes threatening Wall Street’s bottom line,” The Federalist wrote, noting that Big Pharma lobbyists “are almost certainly calling” committee members from both parties.
CHD CEO Mary Holland said the pharmaceutical lobby is “the most powerful one” on Capitol Hill, which makes Kennedy’s confirmation challenging.
Holland added:
“With the president’s strong backing, however, and aligned nominations for key leadership roles under HHS, Kennedy appears to have excellent odds at becoming the next HHS secretary. We hope CHD’s agenda to end the epidemic of chronic childhood diseases will be well served in the new administration…
READ FULL ARTICLE HERE… (childrenshealthdefense.org)
Home | Caravan to Midnight (zutalk.com)
